An Ophthalmic Solution of a Peroxisome Proliferator-activated Receptor Gamma Agonist Prevents Corneal Inflammation in a Rat Alkali Burn Model

Overview

Journal Mol Vis

Specialties Cell Biology
Molecular Biology
Ophthalmology

Date 2013 Nov 7

PMID 24194635

Citations 26

Authors

Masaaki Uchiyama

Akira Shimizu

Yukinari Masuda

Shinya Nagasaka

Yuh Fukuda

Hiroshi Takahashi

Affiliations

Soon will be listed here.

Abstract

Purpose: We clarified the effects of an ophthalmic solution of a peroxisome proliferator-activated receptor gamma (PPARγ) agonist on corneal inflammation and wound healing after alkali burn injury in rats.

Methods: After alkali exposure, either an ophthalmic solution with 0.1% pioglitazone hydrochloride (the PPARγ group) or vehicle (the vehicle group) was topically applied to the cornea until day 14. Histological, immunohistochemical, and real-time reverse transcription polymerase chain reaction analysis were performed.

Results: After alkali injury, PPARγ expression increased, with the infiltration of many inflammatory cells. The infiltration of neutrophils and macrophages started from the corneal limbus within 6 h, and developed in the corneal center by day 7, with associated neovascularization. The accumulation of α-smooth muscle actin-positive myofibroblasts and the deposition of type III collagen were noted on day 14. The histological changes were suppressed significantly by treatment with the ophthalmic solution of the PPARγ agonist. In addition, the number of infiltrating M2 macrophages in the cornea was increased by PPARγ agonist treatment. In real-time reverse transcription polymerase chain reaction analysis, the messenger ribonucleic acid expression levels of interleukin-1β (IL-1β), IL-6, IL-8, monocyte chemoattractant protein-1, tumor necrosis factor-α, transforming growth factor beta 1, and vascular endothelial growth factor-A were decreased in the PPARγ group compared to the vehicle group in the early periods of corneal inflammation.

Conclusions: The ophthalmic solution of the PPARγ agonist inhibited inflammation, decreased the fibrotic reaction, and prevented neovascularization in the cornea from the early phase after alkali burn injury. The ophthalmic solution of the PPARγ agonist may provide a new treatment strategy with useful clinical applications for corneal inflammation and wound healing.

Citing Articles

Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases.

Chow B, Yu Lee I, Liu C, Liu Y Exp Biol Med (Maywood). 2024; 249:10142.

PMID: 38993197 PMC: 11238193. DOI: 10.3389/ebm.2024.10142.

Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy.

Mansoor H, Yu Lee I, Lin M, Ang H, Xue Y, Krishaa L Sci Rep. 2024; 14(1):13435.

PMID: 38862650 PMC: 11167005. DOI: 10.1038/s41598-024-64451-4.

Animal Models for Limbal Stem Cell Deficiency: A Critical Narrative Literature Review.

Atalay E, Altug B, Caliskan M, Ceylan S, Ozler Z, Figueiredo G Ophthalmol Ther. 2024; 13(3):671-696.

PMID: 38280103 PMC: 10853161. DOI: 10.1007/s40123-023-00880-0.

Pathogenesis of Alkali Injury-Induced Limbal Stem Cell Deficiency: A Literature Survey of Animal Models.

Sprogyte L, Park M, Di Girolamo N Cells. 2023; 12(9).

PMID: 37174694 PMC: 10177508. DOI: 10.3390/cells12091294.

Disulfiram Ophthalmic Solution Inhibited Macrophage Infiltration by Suppressing Macrophage Pseudopodia Formation in a Rat Corneal Alkali Burn Model.

Ikebukuro T, Arima T, Kasamatsu M, Nakano Y, Tobita Y, Uchiyama M Int J Mol Sci. 2023; 24(1).

PMID: 36614177 PMC: 9821574. DOI: 10.3390/ijms24010735.

References

Pan H, Chen J, Xu J, Chen M, Ma R . Antifibrotic effect by activation of peroxisome proliferator-activated receptor-gamma in corneal fibroblasts. Mol Vis. 2009; 15:2279-86. PMC: 2776343. View

Saika S, Yamanaka O, Okada Y, Miyamoto T, Kitano A, Flanders K . Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice. Am J Physiol Cell Physiol. 2007; 293(1):C75-86. DOI: 10.1152/ajpcell.00332.2006. View

Saika S, Ikeda K, Yamanaka O, Miyamoto T, Ohnishi Y, Sato M . Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol. 2005; 166(5):1405-18. PMC: 1606395. DOI: 10.1016/S0002-9440(10)62358-9. View

Evans R . The steroid and thyroid hormone receptor superfamily. Science. 1988; 240(4854):889-95. PMC: 6159881. DOI: 10.1126/science.3283939. View

Gao D, Ning N, Hao G, Niu X . Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats. PPAR Res. 2012; 2012:856426. PMC: 3324923. DOI: 10.1155/2012/856426. View

Lee H, Kang H, Park H, Hong S, Kim J, Cho J . Effect of peroxisome proliferator-activated receptor gamma agonists on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Ann Otol Rhinol Laryngol. 2009; 118(10):721-7. DOI: 10.1177/000348940911801007. View

Sarayba M, Li L, Tungsiripat T, Liu N, Sweet P, Patel A . Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand. Exp Eye Res. 2005; 80(3):435-42. DOI: 10.1016/j.exer.2004.10.009. View

Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R . Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol. 2001; 159(2):599-608. PMC: 1850560. DOI: 10.1016/S0002-9440(10)61731-2. View

Saika S, Ooshima A, Shima K, Tanaka S, Ohnishi Y . Collagen types in healing alkali-burned corneal stroma in rabbits. Jpn J Ophthalmol. 1996; 40(3):303-9. View

10.

MAURICE D . The structure and transparency of the cornea. J Physiol. 1957; 136(2):263-86. PMC: 1358888. DOI: 10.1113/jphysiol.1957.sp005758. View

11.

Jiang C, Ting A, Seed B . PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998; 391(6662):82-6. DOI: 10.1038/34184. View

12.

Yu Y, Zhang Z, Wei S, Weiss R, Felder R . Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure. Hypertension. 2011; 59(2):477-84. PMC: 3266457. DOI: 10.1161/HYPERTENSIONAHA.111.182345. View

13.

Paterson C, Williams R, Parker A . Characteristics of polymorphonuclear leukocyte infiltration into the alkali burned eye and the influence of sodium citrate. Exp Eye Res. 1984; 39(6):701-8. DOI: 10.1016/0014-4835(84)90069-1. View

14.

Abdelrahman M, Sivarajah A, Thiemermann C . Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res. 2005; 65(4):772-81. DOI: 10.1016/j.cardiores.2004.12.008. View

15.

Gordon S, Taylor P . Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005; 5(12):953-64. DOI: 10.1038/nri1733. View

16.

Charo I . Macrophage polarization and insulin resistance: PPARgamma in control. Cell Metab. 2007; 6(2):96-8. DOI: 10.1016/j.cmet.2007.07.006. View

17.

Sotozono C, He J, Matsumoto Y, Kita M, Imanishi J, Kinoshita S . Cytokine expression in the alkali-burned cornea. Curr Eye Res. 1997; 16(7):670-6. DOI: 10.1076/ceyr.16.7.670.5057. View

18.

von Knethen A, Brune B . PPARgamma--an important regulator of monocyte/macrophage function. Arch Immunol Ther Exp (Warsz). 2003; 51(4):219-26. View

19.

Wakamatsu K, Ghazizadeh M, Ishizaki M, Fukuda Y, Yamanaka N . Optimizing collagen antigen unmasking in paraffin-embedded tissues. Histochem J. 1997; 29(1):65-72. DOI: 10.1023/a:1026468902409. View

20.

Wagoner M . Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol. 1997; 41(4):275-313. DOI: 10.1016/s0039-6257(96)00007-0. View